Quality of Recovery in Laparoscopic Sleeve Gastrectomy Using Dexmedetomidine Infusion Versus Laparoscopic TAP Block in Combination With Paragastric Neural Block
Recruiting
Phase 2
Phase 3
Interventional Study
Laparoscopic Sleeve Gastrectomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 20 – 60
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Alexandria University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn which is better, combining Dexmedetomidine infusion and paragastric neural block or combining laparoscopic TAP block and paragastric neural block to enhance recovery after laparoscopic sleeve gastrectomy.
The main questions it aims to answer are:
Will using paragastric neural block (PGNB) combined with dexmedetomidine infusion give better recovery or u…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. American Society of Anesthesiologists (ASA) physical status II- III
2. BMI 35- 50 kg/m2
Exclusion Criteria:
1. Significant hepatic, renal, neuromuscular, or cardiac impairments
2. Extreme obesity (BMI \> 50 kg/m2)
3. Patients on current opioid medication
4. Allergies to dex…
Contacts